* The LibreView website is only compatible with certain operating systems and browsers. Please check www.libreview.com for additional information.
The FreeStyle Libre 2 flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people aged 4 and older with diabetes mellitus.
It includes real-time, optional glucose alarms, for those who want or need them, including those with Type 2 diabetes.
Patients should remove the sensor prior to MRI, CT scan, X-ray or diathermy treatment.
The FreeStyle Libre 2 system has all of the FreeStyle Libre system’s features, with the addition of three optional, real-time glucose alarms that are available through the FreeStyle Libre 2 app.* There is a Low Glucose Alarm, High Glucose Alarm and Signal Loss alarm.
The FreeStyle Libre 2 system is indicated for measuring interstitial fluid glucose levels in people aged 4 years and older with diabetes mellitus.
The FreeStyle Libre 2 system is priced the same as the FreeStyle Libre system.
Abbott is working with governments across Canada to secure public coverage for the FreeStyle Libre 2 system.
The FreeStyle Libre 2 flash glucose monitoring system is covered by the Ontario,** Saskatchewan,†† Manitoba‡‡ and Québec§§ public reimbursement programs for eligible patients. Please visit the Ontario website, the Saskatchewan Drug Plan website, the Province of Manitoba website (PDF 488 KB), or the RAMQ¶¶ website for more information.
Most private health insurance companies cover the FreeStyle Libre 2 system. Encourage your patients to ask their private insurance provider if the FreeStyle Libre 2 system is covered for them.
As of August 17, 2022, the FreeStyle Libre 2 flash glucose monitoring system is now reimbursed under RAMQ for Quebecers who are under the age of 18 and living with type 1 diabetes; and those over the age of 18 living with diabetes and who meet the following two criteria: on intensive insulin therapy (insulin pump treatment or ≥3 insulin injections per day) and who have frequent hypoglycemic events despite adherence to a blood sugar management plan.
If your patient qualifies for reimbursement for the FreeStyle Libre 2 flash glucose monitoring system, you can make a request to RAMQ by filling out this formulary: formulaire #8203. Please consult the RAMQ website for additional details.
Please encourage your patient to download the free FreeStyle Libre 2 app* and pair it with their new FreeStyle Libre 2 sensors. The FreeStyle Libre 2 sensor paired with the free FreeStyle Libre 2 app* allows your patient to share glucose data and alarm notifications with others using the LibreLinkUp app.§
If your patient is denied RAMQ coverage but is eligible for private coverage, please contact your Abbott Diabetes Care sales rep so that Abbott Diabetes Care can work directly with the private payer to manage.
No, FreeStyle Libre 2 system sensors and the FreeStyle Libre 2 app* are NOT compatible with FreeStyle Libre system sensors, readers or the FreeStyle LibreLink app.† It is critical that patients use the matching sensors and app to ensure product functionality. The new FreeStyle Libre 2 app* is available through the App Store or Google Play.
The FreeStyle Libre 2 flash glucose monitoring system is the next generation flash glucose monitoring system, with enhanced accuracy1,2 and no routine confirmatory finger pricks required for treatment decisions,‡ even when glucose is low, falling or rapidly changing.
The Target Glucose Range is pre-set to 3.9-10 mmol/L. Patients can adjust their Target Glucose Range via the Settings menu.
The new FreeStyle Libre 2 app* lets users easily share their glucose data with their caregivers using the LibreLinkUp app.§
When caregivers use the LibreLinkUp app,§ they will get glucose readings sent to their phone from their loved one using the FreeStyle Libre 2 app.* Every FreeStyle Libre 2 app* scan is automatically¶ sent to their smartphone, and up to 20 people can view results from a single FreeStyle Libre 2 app* account. With the LibreLinkUp app,§ caregivers will receive alerts the minute their loved one’s glucose levels are too high or too low – so they can take action.
For more information and support, encourage patient to visit LibreLinkUp.com.
When you first start using the FreeStyle Libre 2 system, the alarm is on by default. The user can turn the alarm sound off and use the alarms in vibration mode only. While in vibration mode, the user will receive a Low Glucose Alarm, High Glucose Alarm or Signal Loss Alarm by vibration.
The transmission range is 6 metres (20 feet), unobstructed. If you are out of range, you may not receive glucose alarms.
Do not force close the FreeStyle Libre 2 app.*
Patients may use their FreeStyle Libre 2 system while on an aircraft, so long as they follow any directions from the flight crew.
* The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check this document (PDF) for more information about device compatibility before using the app.
† The FreeStyle LibreLink app and the FreeStyle Libre reader have similar but not identical features. A finger prick test using a blood glucose metre is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycemia or impending hypoglycemia is reported by the FreeStyle LibreLink app or when symptoms do not match the app readings. The FreeStyle Libre sensor communicates with the FreeStyle Libre reader that started it or the FreeStyle LibreLink app that started it. A sensor started by the FreeStyle Libre reader will also communicate with the FreeStyle LibreLink app. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink requires registration with LibreView.
‡ Finger pricks are required if your glucose readings and alarms do not match symptoms or expectations.
§ The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp and the FreeStyle Libre 2 app requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
¶ Use of the FreeStyle Libre 2 app requires registration with LibreView. Automatic upload requires a wireless internet connection or mobile data connection.
** For people managing diabetes with insulin.
†† The FreeStyle Libre 2 flash glucose monitoring system is covered under the Saskatchewan government-sponsored drug plan for those between the ages of 4 and 17 who manage their diabetes with insulin or have hyperinsulinism.
‡‡ As of September 28, 2021, the FreeStyle Libre 2 flash glucose monitoring system is reimbursed under the Manitoba Pharmacare Program for individuals 25 years old and younger who meet eligibility criteria (PDF 488 KB) including a referral from a specialist.
§§ To be eligible for FreeStyle Libre 2 reimbursement in Quebec, criteria is as follows: under the age of 18 and living with type 1 diabetes; over the age of 18, living with diabetes and meets the following two criteria: is on intensive insulin therapy (insulin pump treatment or ≥3 insulin injections per day), and has frequent hypoglycemic events during the last year, despite adherence to a blood sugar management plan.
¶¶ Official Mark of the Régie de l’assurance maladie du Québec.
References:
This site is intended for Canadian Healthcare Professionals only. Visit patient site.
The FreeStyle Libre flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in adults aged 18 years and older with diabetes mellitus. Always read and follow the label/insert.
The FreeStyle Libre 2 flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people aged 4 years and older with diabetes mellitus. Always read and follow the label/insert.
You are now being redirected to a third-party website not under the control of Abbott. Abbott is not responsible for the contents of such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply the endorsement of the linked site by Abbott.
Do you wish to leave this site?
MyFreeStyle.ca is a product-specific website intended only for residents of Canada.
If you are a resident of another country, please visit our global directory to locate the appropriate site for your country.
